Viewing Study NCT06065059

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-02-07 @ 10:18 PM
Study NCT ID: NCT06065059
Status: TERMINATED
Last Update Posted: 2024-08-13
First Post: 2023-09-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
Sponsor: Tango Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Ovarian Cancer View
None Pancreas Cancer View
None Prostate Cancer View
None BRCA1 Mutation View
None BRCA-Mutated Ovarian Carcinoma View
None BRCA-Associated Breast Carcinoma View
None HRD Positive Advanced Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRCA mutant View
None HRD positive View
None solid tumors View
None USP1 View
None TNG348 View